Search Results - "Nilgun, Atakan"

Refine Results
  1. 1

    Adalimumab by Atakan, Nilgun

    Published in Türkderm (01-01-2022)
    “…Adalimumab, an entirely human monoclonal antibody, specifically blocks the cell-surface receptor relationship of tumor necrosis factor-alpha (TNF-α) with p55…”
    Get full text
    Journal Article
  2. 2

    Higher incidence of metabolic syndrome components in vitiligo patients: a prospective cross-sectional study by Tanacan, Efsun, Atakan, Nilgun

    Published in Anais brasileiros de dermatología (01-03-2020)
    “…To investigate the association between vitiligo and metabolic syndrome. A prospective cross-sectional study was conducted between 2014 and 2016. Study (n=155)…”
    Get full text
    Journal Article
  3. 3

    The role of NLRP1 and NLRP3 inflammasomes in the etiopathogeneses of pityriasis lichenoides chronica and mycosis fungoides: an immunohistochemical study by Bostan, Ecem, Gokoz, Ozay, Atakan, Nilgun

    Published in Archives of dermatological research (01-03-2023)
    “…Mycosis fungoides (MF) is the most common subtype of primary cutaneous T cell lymphomas, whereas pityriasis lichenoides chronica (PLC) is a chronic…”
    Get full text
    Journal Article
  4. 4

    The frequency of epicardial fat pads detected by chest x-rays in psoriasis patients by Doğan, Sibel, Esme, Pelin, Gülsün Akpınar, Meltem, Atakan, Nilgun

    Published in Türkderm (01-01-2020)
    “…Background and Design: Psoriasis is a chronic inflammatory skin condition associated with several systemic comorbidities including cardiovascular diseases…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Effects of low pseudoallergen diet on urticarial activity and leukotriene levels in chronic urticaria by Akoglu, Gulsen, Atakan, Nilgun, Çakır, Banu, Kalayci, Omer, Hayran, Mutlu

    Published in Archives of Dermatological Research (01-05-2012)
    “…Pseudoallergens and leukotrienes (LTs) may have a role in chronic urticaria (CU). The aim of our study is to evaluate the response to the low pseudoallergen…”
    Get full text
    Journal Article
  7. 7
  8. 8

    The association between Behçet disease activity and elevated systemic immune-inflammation index: A retrospective observational study in a tertiary care hospital by Mentesoglu, Dilek, Atakan, Nilgün

    Published in The National medical journal of India (01-03-2024)
    “…Background The systemic immune-inflammation index (SII) is a novel marker for predicting the prognosis in patients with various diseases and cancers. We aimed…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Secukinumab by Atakan, Nilgün

    Published in Türkderm (01-01-2022)
    “…Secukinumab is a human immunoglobulin G1/κ monoclonal antibody targeting interleukin-17A. In clinical trials, 77-81% of the secukinumab patients achieved a…”
    Get full text
    Journal Article
  11. 11

    Turkish dermatologists' approach for chronic spontaneous urticaria: A questionnaire based study by Kocatürk, Emek, Piril, Etikan, Oktay, Taskapan, Nilgun, Atakan, Teoman, Erdem, Serap, Utas, Ekin, Savk, Emel, Bulbul Baskan, Rafet, Koca, Sebnem, Aktan

    Published in Zhonghua pi fu ke yi xue za zhi (01-06-2018)
    “…Chronic spontaneous urticaria (CSU) is a common skin disorder which represents a challenge both for the patients and physicians. Guidelines and treatment…”
    Get full text
    Journal Article
  12. 12

    Primary Lymphocytic Cicatricial Alopecia: A Retrospective Analysis of 36 Patients by Neslihan Akdoğan, Ayşen Karaduman, Sibel Ersoy Evans, Aslı Hapa, Gonca Elçin, Gül Erkin, Nilgün Atakan

    Published in İstanbul Medical Journal (01-12-2017)
    “…Introduction: Cicatricial alopecia (CA) is a group of disorders that lead to permanent hair loss due to irreversible damage to hair follicles. The aim of this…”
    Get full text
    Journal Article
  13. 13

    Adalimumab/Adalimumab by Atakan, Nilgun

    Published in Türkderm (01-04-2022)
    “…Adalimumab, an entirely human monoclonal antibody, specifically blocks the cell-surface receptor relationship of tumor necrosis factor-alpha (TNF-[alpha]) with…”
    Get full text
    Journal Article
  14. 14

    Secukinumab/Sekukinumab by Atakan, Nilgun

    Published in Türkderm (01-04-2022)
    “…Secukinumab is a human immunoglobulin G1/k monoclonal antibody targeting interleukin-17A. In clinical trials, 77-81% of the secukinumab patients achieved a…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    The effects of the systemic isotretinoin treatment on ocular surface and meibomian glands: a prospective longitudinal study by Acar Eser, Nazan, Kocabeyoğlu, Sibel, Atakan, Nilgün, Irkec, Murat

    Published in Cutaneous and ocular toxicology (03-04-2022)
    “…To assess the effects of systemic isotretinoin therapy (SIT) on the ocular surface, meibomian glands (MG) and cornea microstructure in acne vulgaris (AV)…”
    Get full text
    Journal Article
  18. 18

    Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: can we define better-responding endotypes? by Kocatürk, Emek, Başkan, Emel Bülbül, Küçük, Özlem Su, Özdemir, Mustafa, Örnek, Sinem, Can, Pelin Kuteyla, Haşal, Eda, Engin, Burhan, Atakan, Nilgün, Alpsoy, Erkan

    Published in Anais brasileiros de dermatología (01-09-2022)
    “…Chronic Spontaneous Urticaria (CSU) is characterized by recurrent wheals and/or angioedema for longer than 6-weeks. Guidelines recommend Omalizumab (Oma) as…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Alterations of the Human Gut Microbiome in Patients With Hidradenitis Suppurativa: A Case-control Study and Review of the Literature by Öğüt, Neslihan Demirel, Hasçelik, Gülşen, Atakan, Nilgün

    Published in Dermatology practical & conceptual (01-10-2022)
    “…Hidradenitis suppurativa (HS) is a chronic and systemic inflammatory disease that extends beyond the skin. The role of gut microbiome (GM) alterations in the…”
    Get full text
    Journal Article